This page will host Events plug-in for all Clarion and trade events.

Upcoming Events

RayzeBio to Present at the 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2023

RayzeBio, Inc., a targeted radiopharmaceutical company developing an innovative pipeline against validated solid tumor targets, today announced that Ken Song, M.D., President and CEO of the Company, will be presenting at the 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2023.

J.P. Morgan Healthcare Conference

Date: Monday, January 9, 2023

Time: 2:00 p.m. - 2:25 p.m. PST

Location: The Westin St. Francis – Golden Gate Room

About RayzeBio

RayzeBio is a biotechnology company focused on improving outcomes for people with cancer by harnessing the power of targeted radioisotopes. With a focus on clinically validated solid tumor targets, RayzeBio is developing novel drug conjugates to deliver potent therapeutic radioisotopes such as Actinium-225, an alpha-emitter. The company is backed by a syndicate of sophisticated healthcare investors and was established in 2020. For additional information, please visit www.rayzebio.com.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  216.62
-5.41 (-2.44%)
AAPL  255.69
-7.08 (-2.69%)
AMD  225.10
-12.93 (-5.43%)
BAC  50.45
-1.07 (-2.07%)
GOOG  250.84
-0.50 (-0.20%)
META  724.85
-8.42 (-1.15%)
MSFT  517.79
+0.13 (0.03%)
NVDA  177.03
-4.13 (-2.28%)
ORCL  271.42
-3.73 (-1.36%)
TSLA  430.28
-12.32 (-2.78%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.